Amarantus Bioscience Launches Online Corporate Communication Channels

SUNNYVALE, Calif., Dec. 11, 2012 /PRNewswire/ -- Amarantus Bioscience, Inc. (AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced the launch of a suite of online digital corporate communication channels to maintain on-going direct communication with shareholders. The Company has launched official portals on various social media channels including Facebook, Twitter, LinkedIn, Google+ and The Chairman's Blog.

The Chairman's Blog is an online communication portal where Amarantus executives will be able to address important topics as they relate to the treatment of apoptosis-related disorders such as Parkinson's and Traumatic Brain Injury, as well as specific points of discussion as they relate to key events at Amarantus. President & CEO Gerald E. Commissiong penned the Company's inaugural blog post "MANF: Arresting cell death in Parkinson's disease, Traumatic Brain Injury, Cardiac Ischemia and more." The blog post can be found online at the official Amarantus Chairman's Blog profile provided below.

"In this environment where there is an increasing need for open dialog and transparency with shareholders, the channels implemented today will allow for streamlined and efficient communication with our shareholders, while maintaining compliance with all securities laws," said Gerald E. Commissiong, President & CEO of Amarantus. "The Chairman's Blog will allow us to have a more open dialogue and give us additional ways to interact with our base."

Links to the new communication tools are here:

Facebook: https://www.facebook.com/amarantusbio

Twitter: https://twitter.com/AmarantusBio

LinkedIn: http://www.linkedin.com/company/2467217?trk=tyah

Google+: https://plus.google.com/u/1/b/110152688579338796390/110152688579338796390/posts

Chairman's Blog Profile: http://www.thechairmansblog.com/author/gerald-commissiong

About Amarantus Bioscience, Inc.

View post:
Amarantus Bioscience Launches Online Corporate Communication Channels